✦ LIBER ✦

Selective Costimulation Modulation with Abatacept: A Look at Quality-of-Life Outcomes in Patients with Rheumatoid Arthritis

✍ Scribed by William J. Shergy

Book ID: 113899895
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 533 KB
Volume: 38
Category: Article
ISSN: 0049-0172
DOI: 10.1016/j.semarthrit.2008.03.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of the Selective Cos

Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study

✍ WESTHOVENS, R.; KREMER, J. M.; MORELAND, L. W.; EMERY, P.; RUSSELL, A. S.; LI, T 📂 Article 📅 2009 🏛 Journal of Rheumatology Publishing Company 🌐 English ⚖ 245 KB

Psoriasiform lesions appearing in three

Psoriasiform lesions appearing in three patients with rheumatoid arthritis during therapeutic administration of abatacept, a selective inhibitor of T-cell costimulation

✍ M. Konsta; E. Rallis; A. Karameris; A. Stratigos; P.P. Sfikakis; A. Iliopoulos 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB

Treatment of rheumatoid arthritis with t

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

✍ Joel M. Kremer; Maxime Dougados; Paul Emery; Patrick Durez; Jean Sibilia; Willia 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

Treatment of rheumatoid arthritis with t

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: Twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

✍ Joel M. Kremer; Maxime Dougados; Paul Emery; Patrick Durez; Jean Sibilia; Willia 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Abstract ## Objective To determine the clinical efficacy, safety, and immunogenicity of abatacept (CTLA‐4Ig), a selective costimulation modulator, in patients with rheumatoid arthritis (RA) that has remained active despite methotrexate (MTX) therapy. ## Methods This was a 12‐month, multicente

Safety of the selective costimulation mo

Safety of the selective costimulation modulator abatacept in rheumatoid arthritis patients receiving background biologic and nonbiologic disease-modifying antirheumatic drugs: A one-year randomized, placebo-controlled study

✍ M. Weinblatt; B. Combe; A. Covucci; R. Aranda; J. C. Becker; E. Keystone 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Obesity is independently associated with

Obesity is independently associated with impaired quality of life in patients with rheumatoid arthritis

✍ Augusto García-Poma; Maria I. Segami; Claudia S. Mora; Manuel F. Ugarte; Henry N 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 120 KB